title: Reply: Adenosine plasma concentration increase by ticagrelor in patients with acute coronary syndrome: no cause for fear in clinical practice.
authors.forename: Laurent
authors.initials: L
authors.lastname: Bonello
authors.forename: Nathalie
authors.initials: N
authors.lastname: Kipson
authors.forename: Julien
authors.initials: J
authors.lastname: Mancini
authors.forename: Corinne
authors.initials: C
authors.lastname: Frere
authors.forename: Franck
authors.initials: F
authors.lastname: Paganelli
authors.forename: Françoise
authors.initials: F
authors.lastname: Dignat-George
authors.forename: Regis
authors.initials: R
authors.lastname: Guieu
mesh_terms: D054058:Acute Coronary Syndrome / Q000097:blood* / Q000188:drug therapy*; D000241:Adenosine / Q000031:analogs & derivatives* / Q000097:blood*; D005260:Female; D006801:Humans; D008297:Male; D058921:Purinergic P2Y Receptor Antagonists / Q000627:therapeutic use*
chemical_list: D058921:Purinergic P2Y Receptor Antagonists; D000241:Adenosine